|
Shubhada Chiplunkar is Principal Investigator & Director at Advanced Centre for Treatment,Research Education in Cancer.〔http://www.austrade.gov.au/multimedia/transcripts/indian-innovation-forum-2013-dr-shubhada-chiplunkar〕 ACTREC is under the Tata Memorial Centre and is one of the leading research organisations in India, where Shubhada leads a team dedicated for basic & translational cancer research.〔http://www.incredb.org/investigator.php?incredb_id=6〕 ==Research Areas== Chiplunkar's research areas include * Understanding the immunobiology of γδ T cells with reference to anti–tumor immunity * Mechanism of immune dysfunction in patients –Role of CD3–zeta chain and Cox * Clonality of TCR and Ig genes in Leukemias and Lymphomas * Crosstalk of NKT cells and Regulatory T cells * Biomarkers for cancer diagnosis and prognosis * Immunotherapy of cancer 〔http://www.actrec.gov.in/pi-webpages/ShubhaChiplunkar/Home.html〕 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Shubhada Chiplunkar」の詳細全文を読む スポンサード リンク
|